Literature DB >> 22909200

Moving away from candidate genes: a 'genome-wise' discovery of gemcitabine myelotoxicity.

Federico Innocenti1.   

Abstract

Entities:  

Year:  2012        PMID： 22909200      PMCID： PMC4131678          DOI： 10.2217/pgs.12.96

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  8 in total

1.  A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.

Authors:  Federico Innocenti; Kouros Owzar; Nancy L Cox; Patrick Evans; Michiaki Kubo; Hitoshi Zembutsu; Chen Jiang; Donna Hollis; Taisei Mushiroda; Liang Li; Paula Friedman; Liewei Wang; Dylan Glubb; Herbert Hurwitz; Kathleen M Giacomini; Howard L McLeod; Richard M Goldberg; Richard L Schilsky; Hedy L Kindler; Yusuke Nakamura; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2011-12-05       Impact factor: 12.531

2.  The limits of genome-wide methods for pharmacogenomic testing.

Authors:  Eric R Gamazon; Andrew D Skol; Minoli A Perera
Journal:  Pharmacogenet Genomics       Date:  2012-04       Impact factor: 2.089

3.  A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.

Authors:  Kazuma Kiyotani; Satoko Uno; Taisei Mushiroda; Atsushi Takahashi; Michiaki Kubo; Naoki Mitsuhata; Shinomi Ina; Chikashi Kihara; Yasutoshi Kimura; Hiroki Yamaue; Koichi Hirata; Yusuke Nakamura; Hitoshi Zembutsu
Journal:  Pharmacogenet Genomics       Date:  2012-04       Impact factor: 2.089

Review 4.  Systemic therapies for pancreatic cancer--the role of pharmacogenetics.

Authors:  Ross A Soo; Wei-Peng Yong; Federico Innocenti
Journal:  Curr Drug Targets       Date:  2012-06       Impact factor: 3.465

Review 5.  Integrating pharmacogenetics into gemcitabine dosing--time for a change?

Authors:  Joseph Ciccolini; Cédric Mercier; Laetitia Dahan; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2011-02-08       Impact factor: 66.675

Review 6.  Clinical pharmacology and pharmacogenetics of gemcitabine.

Authors:  Andrea Wong; Ross A Soo; Wei-Peng Yong; Federico Innocenti
Journal:  Drug Metab Rev       Date:  2009       Impact factor: 4.518

7.  SLCO1B1 variants and statin-induced myopathy--a genomewide study.

Authors:  E Link; S Parish; J Armitage; L Bowman; S Heath; F Matsuda; I Gut; M Lathrop; R Collins
Journal:  N Engl J Med       Date:  2008-07-23       Impact factor: 91.245

8.  The 8q24 gene desert: an oasis of non-coding transcriptional activity.

Authors:  Konrad Huppi; Jason J Pitt; Brady M Wahlberg; Natasha J Caplen
Journal:  Front Genet       Date:  2012-04-30       Impact factor: 4.599
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.